Yahoo
NasdaqCM - Delayed Quote USD

Fortress Biotech, Inc. (FBIOP)

15.10 -0.49 (-3.14%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
68,466
63,262
57,675
84,513
75,743
Cost of Revenue
23,556
20,924
20,879
22,893
30,775
Gross Profit
44,910
42,338
36,796
61,620
44,968
Operating Expense
74,085
112,559
148,036
200,819
248,532
Operating Income
-29,175
-70,221
-111,240
-139,199
-203,564
Net Non Operating Interest Income Expense
-6,103
-7,621
-10,844
-12,312
-12,244
Other Income Expense
181,304
44,307
1,541
-2,122
2,344
Pretax Income
146,026
-33,535
-120,543
-153,633
-213,464
Tax Provision
4,832
-620
312
521
449
Net Income Common Stockholders
103,367
-1,882
-55,890
-68,669
-94,607
Diluted NI Available to Com Stockholders
103,367
-1,882
-55,890
-68,669
-94,607
Total Operating Income as Reported
-29,175
-70,221
-110,379
-142,342
-203,564
Total Expenses
97,641
133,483
168,915
223,712
279,307
Net Income from Continuing & Discontinued Operation
111,818
6,815
-45,997
-60,637
-86,575
Normalized Income
-35,026.62
-19,406.15
-46,173.17
-61,648.99
-87,466.91
Interest Income
3,524
2,485
2,683
3,003
1,398
Interest Expense
7,143
8,709
11,588
11,915
10,417
Net Interest Income
-6,103
-7,621
-10,844
-12,312
-12,244
EBIT
153,169
-24,826
-108,955
-141,718
-203,047
EBITDA
157,765
-20,165
-104,491
-135,721
-193,694
Reconciled Cost of Revenue
23,184
20,521
19,839
20,663
30,775
Reconciled Depreciation
4,596
4,661
4,464
5,997
9,353
Net Income from Continuing Operation Net Minority Interest
111,818
6,815
-45,997
-60,637
-86,575
Total Unusual Items Excluding Goodwill
151,870
26,729
223
1,281
1,129
Total Unusual Items
151,870
26,729
223
1,281
1,129
Normalized EBITDA
5,895
-46,894
-104,714
-137,002
-194,823
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5,025.38
507.85
46.83
269.01
237.09
12/31/2022 - 11/14/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: